NCT06950996Completed
A Clinical Evaluation of AI Solutions Developed in the CHAIMELEON Project for Cancer: Prostate, Lung, Breast, Colon and Rectum
An in Silico External Clinical Validation of AI Solutions for Cancer Management in the CHAIMELEON Project. Applied to 4 Target Types of Cancer (Lung, Breast, Prostate and Colorectal), Collected Through the Routine Delivery of Health Care With no Enrolment Conditinos (Real World Data).
Source: ClinicalTrials.gov · Last updated 30 Apr 2025
Brief summary (registry, in English)
The goal of this observational study is to see how useful an experimental viewer and AI solutions are for clinicians in their daily work. The investigators want to find out if the AI helps clinicians interpret medical images for different types of cancer. The AI solutions aim to: * Classify whether prostate cancer is low or high risk * Classify the histological subtype in breast cancer * Estimate the life expectancy of patients with lung cancer * Determine the size of colon cancer, lymph node involvement and the possibility of metastasis.. * Assess the invasion of sorrounding tissues in the case of rectum cancer. The study will involve clinicians from various centres who will review a set of cases not previously analysed by the AI. Clinicians will do this in two phases: first using only their own expertise and then with the help of the AI solutions. The technical team want to see if the AI solutions assist clinicians and could become useful in the everyday clinical practice. Clinicians will complete a survey to share their feedback on the usability of the platform and how helpful the AI solutions are.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 300 (actual)
- First submitted
- 11 Apr 2025
- Start date
- 1 Sept 2024
- Primary completion date
- 30 Oct 2024
- Lead sponsor
- Instituto de Investigacion Sanitaria La Fe
- Diseases
- Prostate cancer, Lung cancer, Colorectal cancer
- NCT number
- NCT06950996
What you commit to
- Study type: Observational
- Participants enrolled: 300
- From 1 Sept 2024 to the primary completion date, 30 Oct 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- patients with incomplete or low quality data (radiological, pathological or uncomplete clinical data necessary for the ground truth)
Who the study is looking for
- patients with an histological confirmation of cancer diagnosis (prostate, lung, breast, colon or rectum)
- availability of radiological images (MR for prostate and rectum, CT for lung and colon or mammographys for breast).
- enough follow up (12 months for prostate, breast and rectum), 18 months for lung, and 24 months for colon.
Age in the registry: 18 years to 85 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Hospital Universitario Y Politecnico La Fe Coordinator of this site? Confirm its status | Valencia | Spain | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.